London Daily

Focus on the big picture.
Monday, Oct 20, 2025

Are Covid booster jabs necessary?

Are Covid booster jabs necessary?

Evidence about efficacy of additional dose of vaccine is unclear as some raise moral argument

Many rich countries are considering offering people an additional coronavirus vaccine dose. But are these booster shots necessary?

What does the evidence say about booster shots?


The short answer is: it is unclear. Preliminary data shows that people do experience a fall in protective antibody levels weeks and months after getting their jabs, particularly against the highly infectious Delta variant. However, it is unclear what level of antibodies or other tools in the immune system’s armament confer protective immunity.

What is crucial to understand is the level of antibodies or other immune system soldiers, such as T-cells, required to protect from Covid-19, particularly serious illness and death. Once this is measurable, and then protection is seen dropping towards that level, only then would there be a clear case for administering booster vaccines.

World Health Organization (WHO) experts have said there is not enough scientific evidence to support the use of additional shots. But in people with certain underlying conditions that have weakened immune systems, the response to initial shots is far from optimum, so in those cases the argument for booster jabs can be made, especially against the Delta variant, some scientists have argued.

“You get Delta breakthrough cases, especially in over-60s, and [a booster dose] mitigates this. The same will apply to other vulnerable or immune-suppressed groups,” said Danny Altmann, a professor of immunology at Imperial College London. “The ideal would be to have targeted boosting rooted in data and immune monitoring.”

The current evidence on vaccine effectiveness against Delta supported the case for booster jabs for vulnerable individuals, said Dr Simon Clarke, an associate professor in cellular microbiology at the University of Reading.

Should different vaccines be given as booster jabs?


The jury is still out. Generally, it is thought that the different technologies underpinning the jabs allows the immune system to be presented with the same target but in a slightly different way, likely provoking a more diverse immune response.

At the moment, people are offered two doses of the same jab in the UK, but researchers have been exploring whether offering a second dose of a different Covid vaccine – or indeed a third injection different to the initial two – could boost immunity levels. In late June, preliminary data from a study appeared to suggest a third jab could be beneficial, in particular following Oxford/AstraZeneca shots with a Pfizer/BioNTech booster.
Advertisement

“Based on what we’re seeing here, switching over to an RNA vaccine could have some benefits in terms of antibodies,” said Matthew Snape, the chief investigator of the trial and associate professor in paediatrics and vaccinology at Oxford.

But there are concerns about side-effects from mixing and matching jabs. One study presented to the Joint Committee on Vaccination and Immunisation (JCVI) indicated that if people were given a combination of vaccines for their first and second jabs, the side-effects could be worse, with potential implications for the idea of a using a different jab for a booster.

What is the UK’s approach to boosters?


Last week, the health secretary, Sajid Javid, suggested over-50s were likely to be offered a booster at the same time as a flu jab, with the programme expected to begin in early September.

But the JCVI, which advises the government on vaccine policy, has not yet given its final advice on the booster programme. Prof Adam Finn, a JCVI member, said on Thursday the committee was expected to decide which vulnerable groups should be recommended for a third shot.

“We need to focus on individuals who are more likely, if you like, to get sick again if they’ve not got a booster,” he said, but signalled against a routine rollout of third jabs. “We do need more evidence before we can make a firm decision on a much broader booster programme.”

A plan to start offering Covid booster vaccinations in the UK from early September is extremely unlikely to happen, it is understood, given the concerns of JCVI about the clinical benefits and potential wider risks to vaccine confidence, JCVI sources have relayed to the Guardian.

What are other countries doing?


The US president, Joe Biden, said on Wednesday his administration planned to make Covid-19 vaccine booster shots available to all Americans starting on 20 September, as Delta infections surge. Israel has begun giving boosters to over-60s, with the president, Isaac Herzog, already receiving his.

The European Medicines Agency said last month there was not enough evidence to recommend boosters, but some countries have gone ahead anyway. France and Germany are looking at third doses for certain groups from September.

Data from JHU CSSE Covid-19 Data and Our World in Data at 08.39 on 20 August 2021


What’s the argument against booster jabs?


Apart from unclear evidence that they are necessary for most fully vaccinated people, a moral argument against administering booster shots has been made. Providing them while so many people in many parts of the world are still waiting to get their first jab is immoral, WHO experts have said.

“We’re planning to hand out extra lifejackets to people who already have lifejackets, while we’re leaving other people to drown without a single lifejacket,” said Dr Michael Ryan, the director of the WHO’s health emergency programme.

Large-scale boosting in wealthy countries sends a signal around the world that boosters are needed everywhere, according to Andrew Pollard, the director of the Oxford Vaccine Group, and Seth Berkley, the chief executive of Gavi, the Vaccine Alliance, writing in a recent opinion piece published by the Guardian.

“This will suck many vaccine doses out of the system, and many more people will die because they never even had a chance to get a single dose,” they said. “Since we have the two-dose luxury of having time on our side, we should not rush into boosting millions of people while time is running out for those who have nothing. First doses first. It’s that simple.”

Newsletter

Related Articles

0:00
0:00
Close
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
Yachts, Private Jets, and a Picasso Painting: Exposed as 'One of the Largest Frauds in History'
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
Dutch Government Seizes Chipmaker After U.S. Presses for Removal of Chinese CEO
Bessent Accuses China of Dragging Down Global Economy Amid New Trade Curbs
U.S. Revokes Visas of Foreign Nationals Who ‘Celebrated’ Charlie Kirk’s Assassination
AI and Cybersecurity at Forefront as GITEX Global 2025 Kicks Off in Dubai
DJI Loses Appeal to Remove Pentagon’s ‘Chinese Military Company’ Label
EU Deploys New Biometric Entry/Exit System: What Non-EU Travelers Must Know
Australian Prime Minister’s Private Number Exposed Through AI Contact Scraper
Ex-Microsoft Engineer Confirms Famous Windows XP Key Was Leaked Corporate License, Not a Hack
China’s lesson for the US: it takes more than chips to win the AI race
Australia Faces Demographic Risk as Fertility Falls to Record Low
×